NVST Stock Forecast & Price Target

Envista Holdings Corp has recently demonstrated a positive turnaround in key business segments, with Value Implant sales returning to growth after a prior decline and Premium Implant revenue increasing by low single digits year-over-year, particularly in North America. Additionally, significant sales growth was noted in the Wires & Brackets category, contributing to an overall positive sales trajectory. The company also raised its full-year 2025 core sales growth guidance from 1-3% to 3-4%, reflecting confidence in its revenue outlook and market performance.

Envista Holdings Corp reported a small EBIT miss of $0.02, despite posting stronger top-line performance, which signals potential challenges in controlling costs. Furthermore, the company maintained its FY25 EBITDA margin guidance at approximately 14%, while only slightly increasing the midpoint of its core sales growth expectations by 150 basis points, indicating limited growth momentum. Additional risks to the company's stock outlook include heightened competition, unfavorable macroeconomic conditions, regulatory challenges, and reliance on distribution partners, which may hinder its commercial execution.